Hypertensive Cardiovascular Risk: Pulsatile Hemodynamics, Gender, and Therapeutic Implications.

about

Hypertensive Cardiovascular Risk: Pulsatile Hemodynamics, Gender, and Therapeutic Implications.

Item

http://www.wikidata.org/entity/Q50088812

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Hypertensive Cardiovascular Ri ...... and Therapeutic Implications.

@en

Hypertensive Cardiovascular Ri ...... and Therapeutic Implications.

@nl

type

Item

label

Hypertensive Cardiovascular Ri ...... and Therapeutic Implications.

@en

Hypertensive Cardiovascular Ri ...... and Therapeutic Implications.

@nl

prefLabel

Hypertensive Cardiovascular Ri ...... and Therapeutic Implications.

@en

Hypertensive Cardiovascular Ri ...... and Therapeutic Implications.

@nl

P1476

Hypertensive Cardiovascular Ri ...... and Therapeutic Implications.

@en

P2093

Harold Smulyan

http://www.w3.org/2001/XMLSchema#string

Michel E Safar

http://www.w3.org/2001/XMLSchema#string

P2860

Hypertension and vascular dynamics in men and women with metabolic syndrome

Prevention of aortic and cardiac fibrosis by spironolactone in old normotensive rats.

Role of pulse pressure amplification in arterial hypertension: experts' opinion and review of the data.

Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: 'establishing normal and reference values'

Should diastolic and systolic blood pressure be considered for cardiovascular risk evaluation: a study in middle-aged men and women.

Augmentation index as a measure of peripheral vascular disease state.

Sex difference in cardiovascular risk: role of pulse pressure amplification.

Rationale and study design of the Prospective comparison of Angiotensin Receptor neprilysin inhibitor with Angiotensin receptor blocker MEasuring arterial sTiffness in the eldERly (PARAMETER) study.

Antihypertensive therapy and de-stiffening of the arteries.

2A.04: WHETHER ACE INHIBITOR/ARB COMBINED WITH CCB IS SUPERIOR TO OTHER COMBINATIONS? A META-ANALYSIS IN 20,669 HYPERTENSIVES.

P304

947-953

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/AJH/HPX049

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28911022

http://www.w3.org/2001/XMLSchema#string